Terminally differentiated neurons are unable to reenter the cell cycle. Aberrant cell cycle activation provokes neuronal cell death, whereas cell cycle inhibition elevates neuronal survival. However, the molecular mechanism regulating the cell cycle and cell death in mature neurons remains elusive. Here we show that SRPK2, a protein kinase specific for the serine/arginine (SR) family of splicing factors, triggers cell cycle progression in neurons and induces apoptosis through regulation of nuclear cyclin D1. Akt phosphorylates SRPK2 on Thr-492 and promotes its nuclear translocation leading to cyclin D1 up-regulation, cell cycle reentry, and neuronal apoptosis. In addition, SRPK2 phosphorylates SC35 and, thus, inactivates p53, resulting in cyclin D1 up-regulation. 14-3-3 binding to SRPK2, regulated by Akt phosphorylation, inhibits these events. We find that SRPK2 is phosphorylated in ischemia-attacked brain, correlating with the observed increase in cyclin D1 levels. Hence, phosphatidylinositol 3-kinase/Akt mediates the cell cycle and cell death machinery in the nervous system through phosphorylation of SRPK2.In the central nervous system the nascent neuroblasts leave ventricular zone or subventricular zone and migrate to the destination where they differentiate and become permanently post-mitotic cells (1). It is well established that terminally differentiated neurons are unable to reenter the cell cycle, but accumulating evidence has demonstrated the up-regulation of cell cycle regulatory proteins in degenerating neurons of Alzheimer disease (AD) 2 brain (2). Elevated levels of Cdc2, Cdk4, p16, Ki-67, cyclin B1, and cyclin D have been found in pathologically affected or vulnerable neurons in AD (3-7). Moreover, several of these regulators have been observed in vulnerable neurons before lesion formation (8). Together these findings suggest that the activity of certain cell cycle regulators plays a critical upstream role in the AD neurodegenerative process. Greene and co-workers (9 -12) have shown that drugs that block cell cycle advances are efficient in preventing the death of PC12 cells as well as sympathetic neurons. Dominant negative forms of the Cdk4 and Cdk6 preventing the cell death induced by camptothecin (a topoisomerase inhibitor) are effectively blocked by the G 1 /S blockers, such as deferoxamine and mimosine, as well as by the cyclin-dependent kinases (Cdk) inhibitors flavopiridol and olomoucine. In addition, they show that neurons treated with DNA-damaging agents such as UV irradiation or camptothecin also require cyclin D and Cdk4/6 activity to induce neuronal death (13). Thus, this evidence supports that mature neurons might retain certain elements of the cell cycle and have the capability of reactivating additional aspects of the replication mechanism when under stresses. Any events that force a mature neuron back into the cell cycle are lethal rather than mitogenic for the neuron.SRPK, a family of cell cycle-regulated protein kinases, phosphorylate serine/arginine (SR) domain-containing protein...